Received Aug 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPHEPBIP | DTAP + HEPB + IPV (PEDIARIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
Administration after temp. excursion; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 5-year-old male patient who received DTPa-HBV-IPV (Pediarix) for prophylaxis. On 21-AUG-2025 14:48, the patient received Pediarix. On an unknown date, an unknown time after receiving Pediarix, the patient experienced incorrect storage of drug (Verbatim: Administration after temp. excursion). The outcome of the incorrect storage of drug was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 21-AUG-2025 A practice operations manager reported that they had an excursion, and a vaccine (Pediarix) was given to a patient, which led to incorrect storage of drug. The reporter just wants to make sure that it was okay, that it was viable. The vaccine administration facility was the same as primary reporter. The reporter informed that the excursion and vaccination date was on the same day (21-Aug-2025), but the excursion occurred in the morning, and the vaccination at 02:48 PM.